Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection, Clin Infect Dis, vol.20, issue.1, p.7727633, 1995. ,
Approaches to treatment of emerging shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype, Fron Cell Infect Microbiol, vol.5, p.25853096, 2015. ,
Enteropathogenic Escherichia coli: foe or innocent bystander?, Clin Microbiol Infect, 2015. ,
Community acquired multidrug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal, Antimicrob Resist Infect Control, vol.4, p.15, 2015. ,
A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens, Virulence, vol.4, issue.1, pp.1-10, 2014. ,
Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens, J Antimicrob Chemother, vol.69, issue.9, p.24872344, 2014. ,
Phage therapy in the food industry, Annu Rev Food Sci Technol, vol.5, issue.1, pp.327-376, 2014. ,
The next generation of bacteriophage therapy, Curr Opin Microbiol, vol.14, issue.5, pp.524-555, 2011. ,
Effect of bacteriophage in enterotoxigenic Escherichia coli (ETEC) infected pigs, J Vet Med Sci, vol.74, issue.8, p.22446401, 2012. ,
Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine, Antimicrob Agents Chemother, vol.56, issue.12, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01538999
Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh, Virology, vol.434, issue.2, pp.222-254, 2012. ,
Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy, Antimicrob Agents Chemother, vol.49, issue.7, p.15980363, 2005. ,
Challenges and implications for biomedical research and intervention studies in older populations: Insights from the ELDERMET study, Gerontology, vol.59, issue.2, p.23146954, 2013. ,
Gut microbiota composition correlates with diet and health in the elderly, Nature, vol.488, issue.7410, pp.178-84, 2012. ,
Biodiversity of lactococcal bacteriophages isolated from 3 Gouda-type cheese-producing plants, Journal of dairy science, vol.96, issue.8, pp.4945-57, 2013. ,
Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042, PLoS One, vol.5, issue.1, p.8801, 2010. ,
Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69, J Bacteriol, vol.191, issue.1, pp.347-54, 2009. ,
Complete genome sequence of enterohemorrhagic Eschelichia coli O157:H7 and genomic comparison with a laboratory strain K-12, DNA Res, vol.8, issue.1, pp.11-22, 2001. ,
A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407, J Bacteriol, vol.192, issue.21, pp.5822-5853, 2010. ,
Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine, Inflamm Bowel Dis, vol.14, issue.2, p.17941093, 2008. ,
Characterization of the flexible genome complement of the commensal Escherichia coli strain A0 34/86 (O83: K24: H31). Microbiol, vol.151, pp.385-98, 2005. ,
Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection, Infect Immun, vol.69, issue.7, pp.4572-4581, 2001. ,
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains, Infect Immun, vol.58, issue.5, p.2182540, 1990. ,
The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus, J Bacteriol, vol.187, issue.20, pp.7161-7165, 2005. ,
Novel phage group infecting Lactobacillus delbrueckii subsp. lactis, as revealed by genomic and proteomic analysis of bacteriophage Ldl1, Appl Environ Microbiol, vol.81, issue.4, pp.1319-1345, 2015. ,
Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.48, issue.5, p.15105149, 2004. ,
A bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermedius, PLoS One, vol.10, issue.3, p.119684, 2015. ,
Rapid and cost-effective method for micro-organism enumeration based on miniaturization of the conventional plate-counting technique, Lait, vol.86, issue.3, pp.251-258, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00895582
Characterization of virus-like particles associated with the human faecal and caecal microbiota, Res Microbiol, vol.165, issue.10, p.25463385, 2014. ,
Improved microbial gene identification with GLIMMER, Nucleic Acids Res, vol.27, issue.23, p.10556321, 1999. ,
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res, vol.25, issue.17, p.9254694, 1997. ,
The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST), Nucleic Acids Res, vol.42, pp.206-220, 2014. ,
ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences, Nucleic Acids Res, vol.32, issue.1, pp.11-17, 2004. ,
BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons, BMC Genomics, vol.12, p.402, 2011. ,
Exploiting gut bacteriophages for human health, Trends Microbiol, vol.22, issue.7, pp.399-405, 2014. ,
Composition and temporal stability of the gut microbiota in older persons, ISME J, vol.10, issue.1, pp.170-82, 2016. ,
Structure and function of bacteriophage T4, Future Microbiol, vol.9, issue.12, pp.1319-1356, 2014. ,
Bacteriophage vB_EcoM_FV3: a new member of "rV5-like viruses, Arch Virol, vol.157, issue.12, pp.2431-2436, 2012. ,
The host-range, genomics and proteomics of Escherichia coli O157:H7 bacteriophage rV5, Virol J, vol.10, p.76, 2013. ,
Characterization of a T5-like coliphage, SPC35, and differential development of resistance to SPC35 in Salmonella enterica serovar typhimurium and Escherichia coli, Appl Environ Microbiol, vol.77, issue.6, pp.2042-50, 2011. ,
Bacteriophages as biocontrol agents of food pathogens, Curr Opin Biotechnol, vol.22, issue.2, pp.157-63, 2011. ,
Treatment of highly virulent extraintestinal pathogenic Escherichia coli pneumonia with bacteriophages, Crit Care Med, vol.43, issue.6, p.25803649, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01539037
Effective phages as green antimicrobial agents against antibiotic-resistant hospital Escherichia coli, Jundishapur J Microbiol, vol.8, issue.2, p.17744, 2015. ,
Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe, Nat Genet, vol.44, issue.9, pp.1056-1065, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01117702
Comparative genomic analysis of bacteriophage EP23 infecting Shigella sonnei and Escherichia coli, J Microbiol, vol.49, issue.6, pp.927-961, 2011. ,
Lysis from without, Bacteriophage, vol.1, issue.1, pp.46-55, 2011. ,
Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy, PLoS One, vol.10, issue.3, p.118557, 2015. ,
Escherichia coli O157:H7 bacteriophage Phi241 isolated from an industrial cucumber fermentation at high acidity and salinity, Front Microbiol, vol.6, p.67, 2015. ,
What is needed for phage therapy to become a reality in Western medicine?, Virology, vol.434, issue.2, pp.138-180, 2012. ,
Complete genome sequence of T4-Like Escherichia coli bacteriophage HX01, J Virol, vol.86, issue.24, p.13871, 2012. ,
A cocktail of in vitro efficient phages is not a guarantee for in vivo therapeutic results against avian colibacillosis, Vet Microbiol, vol.171, issue.3-4, p.24269008, 2014. ,
Phage therapy: the Escherichia coli experience, Microbiol, vol.151, issue.7, pp.2133-2173, 2005. ,
T4 phages against Escherichia coli diarrhea: potential and problems, Virology, vol.388, issue.1, 2009. ,
Bacteriophages and their genomes, Curr Opin Virol, vol.1, issue.4, pp.298-303, 2011. ,
Characterization of a T5-like coliphage, SPC35, and differential development of resistance to SPC35 in Salmonella enterica serovar Typhimurium and Escherichia coli, Appl Environ Microbiol, vol.77, issue.6, pp.2042-50, 2011. ,
Bacteriophages as an alternative strategy for fighting biofilm development, Polish J Microbiol, vol.63, issue.2, p.25115107, 2014. ,
Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7, Appl Environ Microbiol, vol.70, issue.6, p.15184139, 2004. ,
The factors affecting effectiveness of treatment in phages therapy, Front Microbiol, vol.5, p.51, 2014. ,
Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms, Viruses, vol.6, issue.10, pp.3778-86, 2014. ,
Phage-Antibiotic Synergy (PAS): ?-Lactam and quinolone antibiotics stimulate virulent phage growth, PLoS One, vol.2, issue.8, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00180524
Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity, Appl Environ Microbiol, vol.81, issue.3, pp.1132-1140, 2015. ,